Zogenix Logo and Tagline Zogenix Logo and Tagline
Zogenix Flash Banner

Migraine Manuscripts

Brandes, J., Cady, R., Freitag, F., Smith, T., Chandler, P., Fox, A., Linn, L., Farr, S. “Needle-Free Subcutaneous Sumatriptan (SUMAVEL DosePro): Bioequivalence and Ease of Use” Headache 2009; 49:1435-1444

Migraine Presentations


Improved Treatment Satisfaction and Confidence Among Current Triptan Users Trying SUMAVEL® DosePro® for Up to 4 Migraine Attacks    Improved Treatment Satisfaction and Confidence Among Current Triptan Users Trying SUMAVEL® DosePro® for Up to 4 Migraine Attacks

  • - 63rd Annual Meeting of the American Academy of Neurology,
    April 2011
  • - Annual Meeting of the American Headache Society (AHS),
    June 2011


Multiple-Attack Efficacy and Tolerability of SUMAVEL® DosePro® Among Current Triptan Users   Multiple-Attack Efficacy and Tolerability of SUMAVEL® DosePro® Among Current Triptan Users

  • - 63rd Annual Meeting of the American Academy of Neurology (AAN),
    April 2011
  • - Annual Meeting of the American Headache Society (AHS),
    June 2011


Current Triptan Users Requiring a Change in Migraine Therapy Demonstrated Improved Treatment Satisfaction and Confidence After Trying SUMAVEL® DosePro® for up to 4 Migraine Attacks   Current Triptan Users Requiring a Change in Migraine Therapy Demonstrated Improved Treatment Satisfaction and Confidence After Trying SUMAVEL® DosePro® for up to 4 Migraine Attacks

- Annual Meeting of the American Headache Society (AHS),
June 2011

SUMAVEL® DosePro™
Zogenix Artwork DosePro